THE ENIGMA OF HLA-MEDIATED ADVERSE DRUG REACTIONS: EPOXIDE BUT NOT CARBAMAZEPINE INDUCES THE BINDING OF HAPTENATED PEPTIDES TO HLA-B*15:02

被引：0
作者：
Simper, Gwendolin S. [1 ]
Celik, Alexander A. [1 ]
Ho, Gia-Gia T. [1 ]
Huyton, Trevor [2 ]
Kuhn, Joachim [3 ]
Blasczyk, Rainer [1 ]
Bade-Doeding, Christina [1 ]
机构：
[1] Hannover Med Sch, Hannover, Germany
[2] Max Planck Inst, Gottingen, Germany
[3] Heart & Diabet Ctr North Rhine Westphalia, Bad Oeynhausen, Germany
来源：
HLA | 2018年 / 91卷 / 05期
关键词：
D O I：
暂无
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
O1
引用
收藏
页码：322 / 322
页数：1
相关论文
共 50 条
[1]   Carbamazepine-Mediated Adverse Drug Reactions: CBZ-10,11-epoxide but Not Carbamazepine Induces the Alteration of Peptides Presented by HLA-B*15:02 [J].
Simper, Gwendolin S. ;
Ho, Gia-Gia T. ;
Celik, Alexander A. ;
Huyton, Trevor ;
Kuhn, Joachim ;
Kunze-Schumacher, Heike ;
Blasczyk, Rainer ;
Bade-Doeding, Christina .
JOURNAL OF IMMUNOLOGY RESEARCH, 2018, 2018
[2]   HLA-B*15:11 status and carbamazepine-induced severe cutaneous adverse drug reactions in HLA-B*15:02 negative Chinese [J].
Wong, Christina S. M. ;
Yap, Desmond Y. H. ;
Ip, Patrick ;
Wong, Wilfred H. S. ;
Chua, Gilbert T. ;
Yeung, Chi-Keung ;
Chan, Henry H. L. ;
Kwok, Janette S. Y. .
INTERNATIONAL JOURNAL OF DERMATOLOGY, 2022, 61 (02) :184-190
[3]   Update on HLA-B*15:02 allele associated with adverse drug reactions [J].
Zhu, Xueting ;
Luo, Guanghua ;
Zheng, Lu .
PHARMACOGENOMICS, 2024, 25 (02) :97-111
[4]   Association between HLA-B*15:02 and carbamazepine induced severe cutaneous adverse drug reactions in Myanmar [J].
Khor, Amy Hui-Ping ;
Aye, Seinn Mya Mya ;
Lim, Kheng-Seang ;
Aung, Yan Lynn ;
Aye, Yin Minn ;
Ohnmar ;
Thit, Win Min ;
Tan, Chong-Tin ;
Ng, Ching-Ching .
NEUROLOGY ASIA, 2017, 22 (03) :283-285
[5]   Economic evaluation of HLA-B*15:02 screening for carbamazepine-induced severe adverse drug reactions in Thailand [J].
Rattanavipapong, Waranya ;
Koopitakkajorn, Tanunya ;
Praditsitthikorn, Naiyana ;
Mahasirimongkol, Surakameth ;
Teerawattananon, Yot .
EPILEPSIA, 2013, 54 (09) :1628-1638
[6]   Association of HLA-B*15:13 and HLA-B*15:02 with phenytoin-induced severe cutaneous adverse reactions in a Malay population [J].
C-C Chang ;
C-C Ng ;
C-L Too ;
S-E Choon ;
C-K Lee ;
W-H Chung ;
S H Hussein ;
K-S Lim ;
S Murad .
The Pharmacogenomics Journal, 2017, 17 :170-173
[7]   Association of HLA-B*15:13 and HLA-B*15:02 with phenytoin-induced severe cutaneous adverse reactions in a Malay population [J].
Chang, C-C ;
Ng, C-C ;
Too, C-L ;
Choon, S-E ;
Lees, C-K ;
Chung, W-H ;
Hussein, S. H. ;
Lim, K-S ;
Murad, S. .
PHARMACOGENOMICS JOURNAL, 2017, 17 (02) :170-173
[8]   Implementation of HLA-B*15:02 Genotyping as Standard-of-Care for Reducing Carbamazepine/Oxcarbazepine Induced Cutaneous Adverse Drug Reactions in Thailand [J].
Tiwattanon, Kanyawan ;
John, Shobana ;
Koomdee, Napatrupron ;
Jinda, Pimonpan ;
Rachanakul, Jiratha ;
Jantararoungtong, Thawinee ;
Nuntharadthanaphong, Nutthan ;
Kloypan, Chiraphat ;
Biswas, Mohitosh ;
Boongird, Apisit ;
Sukasem, Chonlaphat .
FRONTIERS IN PHARMACOLOGY, 2022, 13
[9]   Proteome analysis of drug susceptible HLA-B*57:01+ cells reveals the pivotal mechanisms of HLA-mediated carbamazepine hypersensitivity [J].
Haukamp, Funmilola Josephine ;
Hartmann, Zoe Maria ;
Pich, Andreas ;
Kuhn, Joachim ;
Blasczyk, Rainer ;
Stieglitz, Florian ;
Bade-Doeding, Christina .
HLA, 2023, 101 (04) :329-330
[10]   HLA-A*31:01 and HLA-B*15:02 as Genetic Markers for Carbamazepine Hypersensitivity in Children [J].
Amstutz, U. ;
Ross, C. J. D. ;
Castro-Pastrana, L. I. ;
Rieder, M. J. ;
Shear, N. H. ;
Hayden, M. R. ;
Carleton, B. C. .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2013, 94 (01) :142-149
12345